top of page
Search


Emyria Limited – Two-Thirds of PTSD Patients in Remission 12+ Months Post Treatment - Investors Take Note.
The business of metal health is banking on this growing concern in the general population. The statistics for the general population in regards to some form of depression are staggering and I would bet that there would be easily be only one of two separation before you know someone needing help.

Noel Ong
Feb 237 min read


Emyria’s Empax Clinics: Scalable Psychedelic Therapy Meets Growing National Demand
Emyria Limited (ASX: EMD) embodies the fusion of compassionate care, groundbreaking science, and a market in dire need of change. Recently, the company has gained attention by uniquely creating a scalable, evidence-based model for psychedelic-assisted therapy within licensed medical settings in Australia.

Noel Ong
May 19, 20254 min read
bottom of page
